Logo

American Heart Association

  62
  0


Final ID: P1175

Endometriosis diagnosis, staging, and typology in relation to dyslipidemia

Abstract Body: Background: Individuals with endometriosis, a gynecologic condition affecting approximately 11% of people with a uterus, may have an elevated risk for developing cardiovascular disease (CVD) later in life. However, the mechanisms underlying this association are not well understood. Methods: We investigated the association between incident endometriosis diagnosis, staging, and typology and lipid biomarkers measured at time of diagnostic surgery among women participating in the NICHD ENDO study (n=395). Endometriosis was categorized using the American Society for Reproductive Medicine staging (I−IV). Endometriosis typology was defined by lesion depth and location and categorized as superficial endometriosis (SE), ovarian endometrioma (OE), and deep infiltrating endometriosis (DE). With no endometriosis as our reference, we evaluated the associations between endometriosis diagnosis, stage (I/II vs III/IV), and typology (SE, OE, DE, OE+DE) and dyslipidemia using standard clinical thresholds (total cholesterol ≥200 mg/dL, high-density lipoprotein (HDL) <50 mg/dL, low-density lipoprotein (LDL) ≥100 mg/dL, triglycerides ≥175 mg/dL, non-HDL ≥130 mg/dL, VLDL ≥30 mg/dL, Apolipoprotein A-1 (APO-A1) <125 mg/dL, Apolipoprotein B (APOB) ≥120 mg/dL; APOB/APO-A1 ratio >0.78). We calculated adjusted prevalence ratios (aPR) and 95% CIs via generalized linear models, controlling for age, race/ethnicity, marital status, BMI, income (poverty level), and serum cotinine as a marker of smoking. Results: At the time of gynecologic surgery, individuals were mean 32 years (SD: 7 years), non-Hispanic white (79%), married (71%), and mean BMI 28 (SD=8). While we found no differences in endometriosis diagnosis or endometriosis staging and dyslipidemia (Figure 1; Table 1), a pattern emerged regarding endometriosis typology (Table 2). Women with OE+DE, compared to no endometriosis, had increased prevalence of dyslipidemia: total cholesterol >200 mg/dL: 1.87 (0.99, 3.57); triglycerides > 175 mg/dL: 2.48 (1.34, 4.57); VLDL ≥30 mg/dL: 2.08 (1.28, 3.38); and APOB mg/dL ≥120: 2.86 (1.22, 6.66). OE appeared to be driving this association. SE was not associated with dyslipidemia. Conclusions: The association between endometriosis, especially of more severe typology, and subsequent CVD may be through dyslipidemia, which may be detectable at the time of endometriosis diagnosis. Further research in larger, more representative samples is needed before definitive conclusions can be made.
  • Schliep, Karen  ( University of Utah Health , Salt Lake City , Utah , United States )
  • Peterson, Matt  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Stanford, Joseph  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Krall, Jenna  ( George Mason University , Fairfax , Virginia , United States )
  • Page, Jessica  ( Intermountain Health , Salt Lake City , Utah , United States )
  • Farland, Leslie  ( University of Arizona , Tuscon , Arizona , United States )
  • Pollack, Anna  ( George Mason University , Fairfax , Virginia , United States )
  • Rexrode, Kathryn  ( BRIGHAM AND WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Hemmert, Rachael  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Paulsen, Madeline  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Chan, Jessica  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Baradaran, Hediyeh  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Majersik, Jennifer  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Varner, Michael  ( UNIVERSITY UTAH , Salt Lake City , Utah , United States )
  • Author Disclosures:
    Karen Schliep: DO NOT have relevant financial relationships | Matt Peterson: No Answer | Joseph Stanford: No Answer | Jenna Krall: No Answer | Jessica Page: No Answer | Leslie Farland: No Answer | Anna Pollack: DO NOT have relevant financial relationships | Kathryn Rexrode: DO have relevant financial relationships ; Consultant:Astellas:Active (exists now) ; Consultant:Life Force:Active (exists now) | Rachael Hemmert: No Answer | Madeline Paulsen: No Answer | Jessica Chan: DO NOT have relevant financial relationships | Hediyeh Baradaran: No Answer | Jennifer Majersik: No Answer | Michael Varner: No Answer
Meeting Info:
Session Info:

PS01.15 Women's Health

Thursday, 03/06/2025 , 05:00PM - 07:00PM

Poster Session

More abstracts on this topic:
A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) Particles

Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John

Aggressive LDL cholesterol lowering post ACS with triple combination therapy: Insights from the multicentric LAI-REACT study

Puri Raman, Mahajan Kunal, Agarwala Rajeev, Gupta Ashu, Batra Aditya, Khan Aziz, Vijan Vinod, Sharma Jai Bharat, Himral Surender

More abstracts from these authors:
Prevention of Stroke in Women over the Life Course

Miller Eliza, Rexrode Kathryn

Endometriosis diagnosis, staging, and typology in relation to inflammatory cytokines

Shaaban May, Page Jessica, Schliep Karen, Farland Leslie, Pollack Anna, Rexrode Kathryn, Hemmert Rachael, Paulsen Madeline, Ryan Jeanna, Adediran Emmanuel, Peterson Matt

You have to be authorized to contact abstract author. Please, Login
Not Available